New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has highlighted the ...

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has highlighted the ...

Summary: New research provides a breakthrough in understanding the biological mechanisms linking Cannabis Use Disorder (CUD) and psychosis. By conducting a large-scale genetic meta-analysis, ...

A University of California, Riverside preclinical study is shedding light on a long-observed but poorly understood phenomenon ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...

Late 2024 gave us the long-awaited news that a sequel to 2014's Alien: Isolation was finally entering development. Developer Creative Assembly and publisher Sega have been quiet since then, with most ...

The Trump Administration last week moved to reclassify marijuana as a less dangerous drug. Is the goal to reduce America’s collective IQ? The main practical effect of the Justice Department’s ...

Sega and Creative Assembly finally shared a brief teaser for their long-awaited sequel to Alien: Isolation to celebrate Alien Day 2026. The teaser, which you can watch below, is titled "False Sense of ...

This is an edition of the WSJ Weekend Reads newsletter, a weekly look at our most colorful, thought-provoking and original feature stories on the business of life. If you’re not subscribed, sign up ...

Washington — The Justice Department announced Thursday that it has issued an order rescheduling certain marijuana products to a lower drug classification, while moving to expedite the process to ...

(NEXSTAR) – As was roughly anticipated, the Trump administration has moved to partially reclassify marijuana, announcing on Thursday that state-licensed medical marijuana will now be considered a less ...

The Trump administration moved Thursday to reclassify cannabis as a Schedule III drug, a major federal shift recognizing its medicinal use. The change eases restrictions from the U.S. Drug Enforcement ...